PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
Clinical trials for PERIPHERAL ARTERIAL OCCLUSIVE DISEASE explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL ARTERIAL OCCLUSIVE DISEASE trials appear
Sign up with your email to follow new studies for PERIPHERAL ARTERIAL OCCLUSIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug APAC aims to prevent blood clots in leg artery patients
Disease control Recruiting nowThis study tests a new drug called APAC, which is designed to prevent blood clots in people with blocked leg arteries. The trial includes 42 adults with peripheral arterial disease or chronic limb-threatening ischemia. Researchers will check if APAC is safe and well-tolerated, an…
Matched conditions: PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
Phase: PHASE2 • Sponsor: Aplagon Oy • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
PAD patients may get a boost from a single dose of vumerity
Symptom relief Recruiting nowThis early-phase trial tests whether a single dose of Vumerity (diroximel fumarate) can improve blood vessel function and walking ability in 20 people aged 50-75 with peripheral artery disease (PAD). Participants will receive either Vumerity or a placebo, and researchers will mea…
Matched conditions: PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
Phase: EARLY_PHASE1 • Sponsor: University of Nebraska • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC